Sanofi has firmed up its position in the red-hot area of radiopharmaceuticals for cancer with the purchase of a €300 million ($325 million) stake in Orano Med, a subsidiary of French nuclear ...

Molecular Partners leverages DARPins for oncology treatments, but Novartis' exit raises concerns. Click here to read why ...

French uranium mining company Orano says it has sued the government of Niger after the disappearance of its director and the raiding of its local offices DAKAR, Senegal -- French uranium mining ...

Positive IND-enabling data on MP0712 targeting DLL3, the most advanced Radio-DARPin program in co-development with Orano Med, entering clinical development in 2025 First preclinical data of novel ...

Update on IND-enabling data for MP0712, a Radio-DARPin targeting DLL3 and labeled with 212 Pb, co-developed with Orano Med; entering FIH studies in 2025 for the treatment of small cell lung cancer ...

Additionally, they presented initial preclinical data for a second Radio-DARPin targeting mesothelin (MSLN), also co-developed with Orano Med, and further proof-of-concept data on a logic-gated ...

Positive IND-enabling data on MP0712 targeting DLL3, the most advanced Radio-DARPin program in co-development with Orano Med, entering clinical development in 2025 First preclinical data of novel ...